secondary-storefront-menu

International

North America

China

Japan

Latin America

Brazil

Region

Set your region:

single-column

footer-menu-component

footer

secondary-account-menu

Profile

Orders

Wish List

Fast Order Entry

My Account

mega-menu

%1 products have been added to your cart but %2 have been backordered and will be fulfilled when stock is available

Product on backorder

Current quantity limit is [maxProductQuantity], please, navigate to the cart page and change quantity of product

You will be able to resubmit promo in ${countdown} seconds. test

Please note that the taxes displayed on our website are estimated and subject to adjustment. The actual tax charges will be determined and settled during the final invoicing of your order

product-detail-component

footer-legal-menu-component

zone3

products

Marketing materials, training documents, discovery services

cengage:card

FIND YOUR SALES REPRESENTATIVE

cengage:column

Get marketing materials, training documents, discovery services.

PRODUCT SUPPORT

CUSTOMER SUPPORT

Report technical issues, errors, check system status

TECHNICAL SUPPORT

Manage product preferences, generate usage reports, simplify administrative tasks.

ADMIN TOOLS

support

footer-social-menu-component

secondary-primary-menu

cengage:galethorndikeseo

config

zone2

container

footer-legal-menu

Terms of use

Privacy

Browse by Institution Type

Browse by Product Type

Products

Support

footer-social-menu

Sign Up for Emails

CONNECT WITH GALE

Stay up-to-date with the latest Gale news, exclusive offers, and more.

facebook

linkedin

instagram

youtube

SOCIAL ICONS

About Us

Blogs

Press Center

Events

News

Careers

Our Company

Request a Trial

gale-footer

Would you like to go to the Gale {{RECOMMENDED_COUNTRY}} site instead?

It looks like you're visiting from {{DETECTED_COUNTRY}}.

main

footer-menu

Academic Institutions

K-12

Public Libraries

Government and Special Libraries

Statewide Programs

Institutions

Databases

Primary Sources

Digital Humanities Tools

eLearning

Schools/K-12 Curriculum

Books

Large Print Books by Thorndike Press

Find Your Rep

Product Support

Technical Support

Customer Support

Admin Tools

Accessibility Policy

Partnerships

Contact Us

FIND YOUR REP

support-order-2

header-component

header

zone1

You may already have access to Gale content through your institution.

STUDENTS AND RESEARCHERS

support-order-1

Account Information

bundle-connector

Diseases & Conditions

Health, Medicine & Nursing

Gt Product Group

Binding Format

Marketing Imprint Name

B2B GT

CL Carton Count

Imprint Name

B2B & B2C

<EM>The Encyclopedia of Cancer,</EM>Second Edition, provides rapid access to focused information on all topics of cancer research for clinicians, research scientists and advanced students. Given the overwhelming success of the first edition, which appeared in 2001, and fast development in the different fields of cancer research, it has been decided to publish a second fully revised and expanded edition, following the principle concept of the first edition that has proven so successful. 

<p>Recent developments are seeing a dynamic merging of basic and clinical science, with translational research increasingly becoming a new paradigm in cancer research. The merging of different basic and clinical science disciplines towards the common goal of fighting against cancer has long ago called for the establishment of a comprehensive reference source both as a tool to close the language gap between clinical and basic science investigators and as a platform of information for students and informed laymen alike. 

<p>While the First Edition had featured scholarly contributions from approximately 300 scientists/clinicians in one Volume, the Second Edition includes more than 1.000 contributors in 4 Volumes with an A-Z format of more than 7.000 entries. It provides definitions of common acronyms and short definitions of related terms and processes in the form of keyword entries. In addition to the keyword entries, there are detailed essays, which provide comprehensive information on syndromes, genes and molecules, and processes and methods. Each essay is well-structured, with extensive cross-referencing between all entries.

Encyclopedic Reference of Cancer

POST SECONDARY FOUR YEAR

COLFR

COLSO

COLJR

COLSR

ENCYCLOPEDIC REFERENCE OF CANCER

Duration

Duration Unit Of Measure

Transaction Type

Front Cover.
Half Title Page.
Other Frontmatter.
Title Page.
Copyright Page.
Preface.
List of Contributors.
1: AACR.
2: AAV.
3: ABC Transporter.
4: ABL.
5: Accelerated Senescence.
6: Achaete-Scute.
7: Acidosis.
8: Acini.
9: Acquired Mutation.
10: Acrocentric Chromosome.
11: Acromegaly.
12: ACTH.
13: Activating Mutation.
14: Acute Cellular Rejection.
15: Acute Lymphoblastic Leukemia.
16: Acute Lymphocytic Leukemia.
17: Acute Lymphoid Leukemia.
18: Acute Promyelocytic Leukemia (APL).
19: Acute Vascular Rejection.
20: Adaptive Response.
21: Adducts.
22: Adducts to DNA.
23: Adenocarcinoma.
24: Adenoma-Carcinoma Sequence.
25: Adenomatous Polyps.
26: Adenoviral Vector.
27: Adenovirus.
28: Adenylyl Cyclase.
29: ADH.
30: Adherens Junctions.
31: Adhesion.
32: Adhesion Molecules.
33: Adjuvant Therapy.
34: Adoptive Immunotherapy.
35: Adrenal Medulla.
36: AFB1.
37: Aflatoxin B1.
38: Aflatoxins.
39: AFP.
40: AKAPS.
41: AKR.
42: AKT.
43: AKT Signal Transduction Pathway in Oncogenesis.
44: ALA.
45: Aldehyde Dehydrogenase.
46: Aldo-Keto Reductase.
47: ALL.
48: Alleles.
49: Allelic Loss.
50: Allograft.
51: &#x03B1;-Fetoprotein.
52: &#x03B1;-Interferon.
53: ALPS.
54: Alternative Lengthening of Telomeres.
55: Alternative Splicing.
56: Alu Elements.
57: Alu Family.
58: Amino Acid Single Letter Code.
59: 5-Aminolevulinic Acid.
60: Aminopeptidase.
61: AML.
62: AML-1.
63: AML-1/ETO/CBF&#x03B2;/TEL in Chromosomal Translocations.
64: Amplification.
65: Amplified.
66: A-MYB.
67: Anchorage Dependence.
68: Androgen Signaling Pathway.
69: Anemia.
70: Aneuploid.
71: Aneuploidy.
72: Angiogenesis.
73: Annealing.
74: Anoikis.
75: Anoxia.
76: Ansomia.
77: Anthracycline.
78: Antibody.
79: Antiestrogen.
80: Antigen.
81: Antigen Processing.
82: Antigen Retrieval.
83: Antigen-Presenting Cells.
84: Antioxidant Defences.
85: Antisense DNA Therapy.
86: Antisense Nucleic Acid.
87: AP.
88: AP-1.
89: AP-2.
90: AP2.
91: APAF-1.
92: APAF-3.
93: APC.
94: APC Gene in Familial Adenomatous Polyposis.
95: APC/&#x03B2;-Catenin Pathway.
96: Aphidicolin.
97: API3.
98: APL.
99: APO-1.
100: Apopain.
101: Apoptosis.
102: APT1.
103: Apudoma.
104: ARE.
105: ARF.
106: Argentaffinoma.
107: Aromatase.
108: Asbestos.
109: ASCO.
110: ASK1.
111: Askin Tumor.
112: Association Genetics.
113: Astrocytic Tumor.
114: Astrocytoma.
115: AT/RT.
116: Ataxia Telangiectasia.
117: ATM Protein.
118: Atonal Family.
119: ATR.
120: Atrophic Gastritis.
121: ATRX.
122: Atypia.
123: Autocrine.
124: Autocrine Stimulation.
125: Autograft.
126: Autoimmune Disease.
127: Autoimmune Lymphoproliferative Syndrome.
128: Autonomic Nervous System.
129: Autophagosome.
130: Autophagy.
131: Autophosphorylation.
132: Autosomes.
133: Aza-Arenes.
134: BAC.
135: Baculovirus IAP Repeat.
136: BAD.
137: BAGE.
138: Bak1.
139: Balanced Translocation.
140: Band.
141: Barrett Adenocarcinoma.
142: Barrett Esophagus.
143: Basal Cell Carcinoma.
144: Basal Cell Nevus Syndrome.
145: Base Pair.
146: Basement Membrane.
147: BAX.
148: BCC.
149: BCDF.
150: B-cell Differentiation Factor.
151: B-cell Diseases of the Immunopoiesis.
152: B-cell Non-Hodgkin Lymphomas.
153: B-cell Stimulating Factor-2.
154: B-cell Tumours.
155: BCG.
156: BCL-2.
157: BCL2L.
158: BCL2L1.
159: BCL2L7.
160: BCL2-Like 1.
161: BCL6.
162: BCL6 Translocations in B-cell Tumors.
163: BCL2L8.
164: BCL-X.
165: BCL-XL.
166: BCL-XS.
167: BCNS.
168: BCR-ABL1.
169: Beckwith-Wiedemann Syndrome Associated Childhood Tumours.
170: Beclin1.
171: Becn1.
172: Benign Tumor.
173: Berlin Breakage Syndrome.
174: Betel Quid.
175: BHD Syndrome.
176: BHLH.
177: BID.
178: BIK.
179: Bilateral A coustic Neurofibromatosis.
180: A Biological Marker.
181: Biologically Effective Dose.
182: Biomarkers.
183: Biomonitoring.
184: Bioreductive Drug.
185: Biosynthesis.
186: BIR.
187: BIRC4.
188: Birt Hogg Dube Syndrome.
189: B-K Mole Syndrome.
190: Bladder Cancer.
191: Blast Crisis.
192: Bloom Syndrome.
193: B Lymphocytes.
Front Cover.
Half Title Page.
Other Frontmatter.
Title Page.
Copyright Page.
Preface.
List of Contributors.
1: AACR.
2: AAV.
3: ABC Transporter.
4: ABL.
5: Accelerated Senescence.
6: Achaete-Scute.
7: Acidosis.
8: Acini.
9: Acquired Mutation.
10: Acrocentric Chromosome.
11: Acromegaly.
12: ACTH.
13: Activating Mutation.
14: Acute Cellular Rejection.
15: Acute Lymphoblastic Leukemia.
16: Acute Lymphocytic Leukemia.
17: Acute Lymphoid Leukemia.
18: Acute Promyelocytic Leukemia (APL).
19: Acute Vascular Rejection.
20: Adaptive Response.
21: Adducts.
22: Adducts to DNA.
23: Adenocarcinoma.
24: Adenoma-Carcinoma Sequence.
25: Adenomatous Polyps.
26: Adenoviral Vector.
27: Adenovirus.
28: Adenylyl Cyclase.
29: ADH.
30: Adherens Junctions.
31: Adhesion.
32: Adhesion Molecules.
33: Adjuvant Therapy.
34: Adoptive Immunotherapy.
35: Adrenal Medulla.
36: AFB1.
37: Aflatoxin B1.
38: Aflatoxins.
39: AFP.
40: AKAPS.
41: AKR.
42: AKT.
43: AKT Signal Transduction Pathway in Oncogenesis.
44: ALA.
45: Aldehyde Dehydrogenase.
46: Aldo-Keto Reductase.
47: ALL.
48: Alleles.
49: Allelic Loss.
50: Allograft.
51: &#x03B1;-Fetoprotein.
52: &#x03B1;-Interferon.
53: ALPS.
54: Alternative Lengthening of Telomeres.
55: Alternative Splicing.
56: Alu Elements.
57: Alu Family.
58: Amino Acid Single Letter Code.
59: 5-Aminolevulinic Acid.
60: Aminopeptidase.
61: AML.
62: AML-1.
63: AML-1/ETO/CBF&#x03B2;/TEL in Chromosomal Translocations.
64: Amplification.
65: Amplified.
66: A-MYB.
67: Anchorage Dependence.
68: Androgen Signaling Pathway.
69: Anemia.
70: Aneuploid.
71: Aneuploidy.
72: Angiogenesis.
73: Annealing.
74: Anoikis.
75: Anoxia.
76: Ansomia.
77: Anthracycline.
78: Antibody.
79: Antiestrogen.
80: Antigen.
81: Antigen Processing.
82: Antigen Retrieval.
83: Antigen-Presenting Cells.
84: Antioxidant Defences.
85: Antisense DNA Therapy.
86: Antisense Nucleic Acid.
87: AP.
88: AP-1.
89: AP-2.
90: AP2.
91: APAF-1.
92: APAF-3.
93: APC.
94: APC Gene in Familial Adenomatous Polyposis.
95: APC/&#x03B2;-Catenin Pathway.
96: Aphidicolin.
97: API3.
98: APL.
99: APO-1.
100: Apopain.
101: Apoptosis.
102: APT1.
103: Apudoma.
104: ARE.
105: ARF.
106: Argentaffinoma.
107: Aromatase.
108: Asbestos.
109: ASCO.
110: ASK1.
111: Askin Tumor.
112: Association Genetics.
113: Astrocytic Tumor.
114: Astrocytoma.
115: AT/RT.
116: Ataxia Telangiectasia.
117: ATM Protein.
118: Atonal Family.
119: ATR.
120: Atrophic Gastritis.
121: ATRX.
122: Atypia.
123: Autocrine.
124: Autocrine Stimulation.
125: Autograft.
126: Autoimmune Disease.
127: Autoimmune Lymphoproliferative Syndrome.
128: Autonomic Nervous System.
129: Autophagosome.
130: Autophagy.
131: Autophosphorylation.
132: Autosomes.
133: Aza-Arenes.
134: BAC.
135: Baculovirus IAP Repeat.
136: BAD.
137: BAGE.
138: Bak1.
139: Balanced Translocation.
140: Band.
141: Barrett Adenocarcinoma.
142: Barrett Esophagus.
143: Basal Cell Carcinoma.
144: Basal Cell Nevus Syndrome.
145: Base Pair.
146: Basement Membrane.
147: BAX.
148: BCC.
149: BCDF.
150: B-cell Differentiation Factor.
151: B-cell Diseases of the Immunopoiesis.
152: B-cell Non-Hodgkin Lymphomas.
153: B-cell Stimulating Factor-2.
154: B-cell Tumours.
155: BCG.
156: BCL-2.
157: BCL2L.
158: BCL2L1.
159: BCL2L7.
160: BCL2-Like 1.
161: BCL6.
162: BCL6 Translocations in B-cell Tumors.
163: BCL2L8.
164: BCL-X.
165: BCL-XL.
166: BCL-XS.
167: BCNS.
168: BCR-ABL1.
169: Beckwith-Wiedemann Syndrome Associated Childhood Tumours.
170: Beclin1.
171: Becn1.
172: Benign Tumor.
173: Berlin Breakage Syndrome.
174: Betel Quid.
175: BHD Syndrome.
176: BHLH.
177: BID.
178: BIK.
179: Bilateral A coustic Neurofibromatosis.
180: A Biological Marker.
181: Biologically Effective Dose.
182: Biomarkers.
183: Biomonitoring.
184: Bioreductive Drug.
185: Biosynthesis.
186: BIR.
187: BIRC4.
188: Birt Hogg Dube Syndrome.
189: B-K Mole Syndrome.
190: Bladder Cancer.
191: Blast Crisis.
192: Bloom Syndrome.
193: B Lymphocytes.

Encyclopedic Reference of Cancer.css-1p8rvzy{position:absolute;padding-left:8px;}

Encyclopedic Reference of Cancer